This activity is no longer available for credit, however its content is still (may still be) relevant for your educational needs.
Valid: February 15th, 2010 - February 15th, 2011
This activity was developed for pharmacists and other healthcare professionals practicing in a managed care environment.
At the completion of this activity participants should be able to:
- Provide payers with a practical understanding of the key clinical, business, and regulatory factors, guidelines, and research advances involving breast cancer treatment that providers are using as the basis for their treatment decisions
- Offer payers a multistakeholder commentary on this information, to identify the impact on different stakeholders of these changes to treatment
- Illuminate the different perspectives and incentives of the various stakeholders involved in breast cancer treatment decisions—patients, providers, payers, purchasers, distributors, regulatory agencies, and manufacturers
- Align incentives with providers, and transform payer drug management policies into patient-centered, value-based models
Estimated time to complete activity: 1 hour
MLI is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Completion of this activity provides for 1.0 contact hours (0.1 CEU) of continuing education credit. The universal program number for this activity is 0468-9999-10-011-H01-P.
Before the activity, all faculty will disclose the existence of any financial interest and/or relationship(s) they might have with the manufacturer(s) of any commercial product(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakerâ€™s bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions.
The associates of Medical Learning Institute, Inc., and Center of Excellence Media, LLC, have no financial relationships to disclose.
James Kenney, RPh, MBA, has nothing to disclose.
*Content will include non-FDA-approved uses.
The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.